Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Characterization and source identification of biological ice nucleating particles deposited year-round in subtropical precipitation.

Joyce R, Lavender H, Farrar J, Werth JT, Weber CF, D'Andrilli J, Vaitilingom M, Christner BC.

Appl Environ Microbiol. 2019 Sep 27. pii: AEM.01567-19. doi: 10.1128/AEM.01567-19. [Epub ahead of print]

PMID:
31562166
2.

baerhunter: An R package for the discovery and analysis of expressed non-coding regions in bacterial RNA-seq data.

Ozuna A, Liberto D, Joyce RM, Arnvig KB, Nobeli I.

Bioinformatics. 2019 Aug 16. pii: btz643. doi: 10.1093/bioinformatics/btz643. [Epub ahead of print]

PMID:
31418770
3.

Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma.

Abramson JS, Arnason JE, LaCasce AS, Redd R, Barnes JA, Sokol L, Joyce R, Avigan D, Neuberg D, Takvorian RW, Hochberg EP, Bello CM.

Blood. 2019 Aug 15;134(7):606-613. doi: 10.1182/blood.2019001272. Epub 2019 Jun 11.

PMID:
31186274
4.

Significant and Distinctive n-Grams in Oncology Notes: A Text-Mining Method to Analyze the Effect of OpenNotes on Clinical Documentation.

Rahimian M, Warner JL, Jain SK, Davis RB, Zerillo JA, Joyce RM.

JCO Clin Cancer Inform. 2019 Jun;3:1-9. doi: 10.1200/CCI.19.00012.

5.

Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition.

Dewan AK, Gupta S, Bach DQ, Jadeja S, Granter S, LaCasce A, Joyce R, Davids MS, Huang V, LeBoeuf NR.

JAAD Case Rep. 2019 Apr 20;5(5):401-405. doi: 10.1016/j.jdcr.2018.03.005. eCollection 2019 May. No abstract available.

6.

Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia.

Lampson BL, Kim HT, Davids MS, Abramson JS, Freedman AS, Jacobson CA, Armand PA, Joyce RM, Arnason JE, Rassenti LZ, Kipps TJ, Fein J, Fernandes SM, Hanna JR, Fisher DC, Brown JR.

Blood Adv. 2019 Apr 9;3(7):1167-1174. doi: 10.1182/bloodadvances.2018030221.

7.

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation.

Armand P, Chen YB, Redd RA, Joyce RM, Bsat J, Jeter E, Merryman RW, Coleman KC, Dahi PB, Nieto Y, LaCasce AS, Fisher DC, Ng SY, Odejide OO, Freedman AS, Kim AI, Crombie JL, Jacobson CA, Jacobsen ED, Wong JL, Patel SS, Ritz J, Rodig SJ, Shipp MA, Herrera AF.

Blood. 2019 Jul 4;134(1):22-29. doi: 10.1182/blood.2019000215. Epub 2019 Apr 5.

PMID:
30952672
8.

Alkylphenol inverse agonists of HCN1 gating: H-bond propensity, ring saturation and adduct geometry differentially determine efficacy and potency.

Joyce RL, Beyer NP, Vasilopoulos G, Woll KA, Hall AC, Eckenhoff RG, Barman DN, Warren JD, Tibbs GR, Goldstein PA.

Biochem Pharmacol. 2019 May;163:493-508. doi: 10.1016/j.bcp.2019.02.013. Epub 2019 Feb 13.

PMID:
30768926
9.

Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma.

Blombery P, Thompson E, Ryland GL, Joyce R, Byrne DJ, Khoo C, Lade S, Hertzberg M, Hapgood G, Marlton P, Deva A, Lindeman G, Fox S, Westerman D, Prince M.

Oncotarget. 2018 Nov 16;9(90):36126-36136. doi: 10.18632/oncotarget.26308. eCollection 2018 Nov 16.

10.

The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure identifies high levels of coexistent psychiatric symptomatology in patients referred for insomnia treatment.

Meaklim H, Swieca J, Junge M, Laska I, Kelly D, Joyce R, Cunnington D.

Nat Sci Sleep. 2018 Nov 5;10:377-383. doi: 10.2147/NSS.S173381. eCollection 2018.

11.

Reduced-Intensity Conditioning Regimens, Prior Chronic Lymphocytic Leukemia, and Graft-Versus-Host Disease Are Associated with Higher Rates of Skin Cancer after Allogeneic Hematopoietic Stem Cell Transplantation.

Wu PA, Stern RS, Huang V, Liu KX, Chen CA, Tzachanis D, Joyce RM, Davis RB, Ho VT.

J Invest Dermatol. 2019 Mar;139(3):591-599. doi: 10.1016/j.jid.2018.08.025. Epub 2018 Oct 11.

PMID:
30316899
12.

Canonical PRC2 function is essential for mammary gland development and affects chromatin compaction in mammary organoids.

Michalak EM, Milevskiy MJG, Joyce RM, Dekkers JF, Jamieson PR, Pal B, Dawson CA, Hu Y, Orkin SH, Alexander WS, Lindeman GJ, Smyth GK, Visvader JE.

PLoS Biol. 2018 Aug 6;16(8):e2004986. doi: 10.1371/journal.pbio.2004986. eCollection 2018 Aug.

13.

Barriers and facilitators to the access to and use of formal dementia care: findings of a focus group study with people with dementia, informal carers and health and social care professionals in eight European countries.

Stephan A, Bieber A, Hopper L, Joyce R, Irving K, Zanetti O, Portolani E, Kerpershoek L, Verhey F, de Vugt M, Wolfs C, Eriksen S, Røsvik J, Marques MJ, Gonçalves-Pereira M, Sjölund BM, Jelley H, Woods B, Meyer G; Actifcare Consortium.

BMC Geriatr. 2018 Jun 4;18(1):131. doi: 10.1186/s12877-018-0816-1.

14.

A Fully Integrated Quartz MEMS VHF TCXO.

Kubena RL, Stratton FP, Nguyen HD, Kirby DJ, Chang DT, Joyce RJ, Yong YK, Garstecki JF, Cross MD, Seman SE.

IEEE Trans Ultrason Ferroelectr Freq Control. 2018 Jun;65(6):904-910. doi: 10.1109/TUFFC.2017.2786248.

PMID:
29856706
15.

Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.

Nahas MR, Soiffer RJ, Kim HT, Alyea EP 3rd, Arnason J, Joyce R, Antin JH, Ho VT, Stroopinsky D, Li S, Levine JD, McMasters M, Jain S, Hamdan A, Tzachanis D, Bryant MP, Logan EK, Bazemore J, Stewart J, Joyce A, Stephenson S, Washington A, Cole L, Pyzer A, Leaf RK, Avigan DE, Rosenblatt J.

Blood. 2018 Jun 21;131(25):2836-2845. doi: 10.1182/blood-2017-05-780239. Epub 2018 Mar 16.

PMID:
29549175
16.

Association of built environment characteristics with adiposity and glycaemic measures.

Lee JJ, Hwang SJ, Mutalik K, Corey D, Joyce R, Block JP, Fox CS, Powell-Wiley TM.

Obes Sci Pract. 2017 Jul 11;3(3):333-341. doi: 10.1002/osp4.115. eCollection 2017 Sep.

17.

Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance-conferring FLT3/tyrosine kinase domain/F691 mutation.

Fathi AT, Blonquist TM, Hernandez D, Amrein PC, Ballen KK, McMasters M, Avigan DE, Joyce R, Logan EK, Hobbs G, Brunner AM, Joseph C, Perry AM, Burke M, Behnan T, Foster J, Bergeron MK, Moran JA, Ramos AY, Som TT, Rae J, Fishman KM, McGregor KL, Connolly C, Neuberg DS, Levis MJ.

Cancer. 2018 Jan 15;124(2):306-314. doi: 10.1002/cncr.31038. Epub 2017 Sep 28. Erratum in: Cancer. 2018 May 15;124(10 ):2258.

18.

Perspectives of policy and political decision makers on access to formal dementia care: expert interviews in eight European countries.

Broda A, Bieber A, Meyer G, Hopper L, Joyce R, Irving K, Zanetti O, Portolani E, Kerpershoek L, Verhey F, Vugt M, Wolfs C, Eriksen S, Røsvik J, Marques MJ, Gonçalves-Pereira M, Sjölund BM, Woods B, Jelley H, Orrell M, Stephan A; ActifCare Consortium.

BMC Health Serv Res. 2017 Aug 3;17(1):518. doi: 10.1186/s12913-017-2456-0.

19.

Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.

Martin P, Chen Z, Cheson BD, Robinson KS, Williams M, Rajguru SA, Friedberg JW, van der Jagt RH, LaCasce AS, Joyce R, Ganjoo KN, Bartlett NL, Lemieux B, VanderWalde A, Herst J, Szer J, Bar MH, Cabanillas F, Dodds AJ, Montgomery PG, Pressnail B, Ellis T, Smith MR, Leonard JP.

Br J Haematol. 2017 Jul;178(2):250-256. doi: 10.1111/bjh.14667. Epub 2017 Apr 17.

20.

MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.

Pyzer AR, Stroopinsky D, Rajabi H, Washington A, Tagde A, Coll M, Fung J, Bryant MP, Cole L, Palmer K, Somaiya P, Karp Leaf R, Nahas M, Apel A, Jain S, McMasters M, Mendez L, Levine J, Joyce R, Arnason J, Pandolfi PP, Kufe D, Rosenblatt J, Avigan D.

Blood. 2017 Mar 30;129(13):1791-1801. doi: 10.1182/blood-2016-07-730614. Epub 2017 Jan 26.

21.

Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions.

Rosenblatt J, Stone RM, Uhl L, Neuberg D, Joyce R, Levine JD, Arnason J, McMasters M, Luptakova K, Jain S, Zwicker JI, Hamdan A, Boussiotis V, Steensma DP, DeAngelo DJ, Galinsky I, Dutt PS, Logan E, Bryant MP, Stroopinsky D, Werner L, Palmer K, Coll M, Washington A, Cole L, Kufe D, Avigan D.

Sci Transl Med. 2016 Dec 7;8(368):368ra171.

22.

A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphoma.

Armand P, Redd R, Bsat J, Mayuram S, Giardino A, Fisher DC, LaCasce AS, Jacobson C, Davids MS, Brown JR, Weng L, Wilkins J, Faham M, Freedman AS, Joyce R, Jacobsen ED.

Br J Haematol. 2016 Apr;173(1):89-95. doi: 10.1111/bjh.13929. Epub 2016 Jan 5.

PMID:
26729345
23.

Continuous positive airway pressure-associated cutaneous amoebiasis in an immunosuppressed patient.

Sells RE, Chen CA, Wong MT, Zimarowski MJ, Kirby JE, Joyce RM, Wu PA.

Br J Dermatol. 2016 Mar;174(3):625-8. doi: 10.1111/bjd.14231. Epub 2016 Jan 5.

PMID:
26474324
24.

Inherited CHST11/MIR3922 deletion is associated with a novel recessive syndrome presenting with skeletal malformation and malignant lymphoproliferative disease.

Chopra SS, Leshchiner I, Duzkale H, McLaughlin H, Giovanni M, Zhang C, Stitziel N, Fingeroth J, Joyce RM, Lebo M, Rehm H, Vuzman D, Maas R, Sunyaev SR, Murray M, Cassa CA.

Mol Genet Genomic Med. 2015 Sep;3(5):413-23. doi: 10.1002/mgg3.152. Epub 2015 May 10.

25.

Development and validation of an ultra-performance liquid chromatography quadrupole time of flight mass spectrometry method for rapid quantification of free amino acids in human urine.

Joyce R, Kuziene V, Zou X, Wang X, Pullen F, Loo RL.

Amino Acids. 2016 Jan;48(1):219-34. doi: 10.1007/s00726-015-2076-0. Epub 2015 Aug 29.

26.

Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma.

Jain S, Stroopinsky D, Yin L, Rosenblatt J, Alam M, Bhargava P, Clark RA, Kupper TS, Palmer K, Coll MD, Rajabi H, Pyzer A, Bar-Natan M, Luptakova K, Arnason J, Joyce R, Kufe D, Avigan D.

Blood. 2015 Jul 16;126(3):354-62. doi: 10.1182/blood-2015-02-628149. Epub 2015 Jun 5.

27.

Yttrium-90 ibritumomab tiuxetan followed by rituximab maintenance as treatment for patients with diffuse large B-cell lymphoma are not candidates for autologous stem cell transplant.

Arnason JE, Luptakova K, Rosenblatt J, Tzachanis D, Avigan D, Zwicker JI, Levine J, Kim M, Parker JA, Grant B, Joyce RM.

Acta Haematol. 2015;133(4):347-53. doi: 10.1159/000368291. Epub 2015 Feb 7.

PMID:
25677780
28.

Incidence and mechanisms of cerebral ischemia after transcatheter aortic valve implantation compared with surgical aortic valve replacement.

Alassar A, Soppa G, Edsell M, Rich P, Roy D, Chis Ster I, Joyce R, Valencia O, Barrick T, Howe F, Moat N, Morris R, Markus HS, Jahangiri M.

Ann Thorac Surg. 2015 Mar;99(3):802-8. doi: 10.1016/j.athoracsur.2014.09.054. Epub 2015 Jan 10.

PMID:
25586706
29.

Primary cardiac burkitt lymphoma presenting with abdominal pain.

Tzachanis D, Dewar R, Luptakova K, Chang JD, Joyce RM.

Case Rep Hematol. 2014;2014:687598. doi: 10.1155/2014/687598. Epub 2014 Nov 6.

30.

A 78-year-old man with acute myeloid leukemia (AML) and acute renal failure.

Tapper EB, Luptakova K, Joyce RM, Tzachanis D.

Am J Case Rep. 2014 Aug 30;15:364-7. doi: 10.12659/AJCR.890798.

31.

Size-exclusion chromatographic NMR of polymer mixtures.

Lucena Alcalde G, Joyce RE, Day IJ.

Magn Reson Chem. 2014 Dec;52(12):760-3. doi: 10.1002/mrc.4127. Epub 2014 Aug 22.

PMID:
25155543
32.

Sequential infusion of donor-derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantation.

Ho VT, Kim HT, Kao G, Cutler C, Levine J, Rosenblatt J, Joyce R, Antin JH, Soiffer RJ, Ritz J, Avigan D, Alyea EP 3rd.

Am J Hematol. 2014 Dec;89(12):1092-6. doi: 10.1002/ajh.23825. Epub 2014 Aug 27.

33.

Rifaximin suppresses background intestinal 18F-FDG uptake on PET/CT scans.

Franquet E, Palmer MR, Gifford AE, Selen DJ, Chen YC, Sedora-Roman N, Joyce RM, Kolodny GM, Moss AC.

Nucl Med Commun. 2014 Oct;35(10):1026-31. doi: 10.1097/MNM.0000000000000170.

PMID:
25076161
34.

Substrate specificity of the lanthipeptide peptidase ElxP and the oxidoreductase ElxO.

Ortega MA, Velásquez JE, Garg N, Zhang Q, Joyce RE, Nair SK, van der Donk WA.

ACS Chem Biol. 2014 Aug 15;9(8):1718-25. doi: 10.1021/cb5002526. Epub 2014 Jun 6.

35.
36.

An unusual patient with shortness of breath--clinical, radiologic, and pathologic pitfalls.

Bogusz AM, Joyce R, Kolodny G, Buck T, Pihan G, Bhargava P.

Am J Hematol. 2014 May;89(5):558-63. doi: 10.1002/ajh.23689. No abstract available.

37.

Pancreatic atrophy in patients with chronic graft-versus-host disease.

Brook OR, Mullan CP, Mendiratta-Lala M, Joyce R, Sheiman R, Brook A, Siewert B.

Abdom Imaging. 2014 Apr;39(2):342-7. doi: 10.1007/s00261-013-0072-y.

PMID:
24441578
38.

MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells.

Stroopinsky D, Rosenblatt J, Ito K, Mills H, Yin L, Rajabi H, Vasir B, Kufe T, Luptakova K, Arnason J, Nardella C, Levine JD, Joyce RM, Galinsky I, Reiter Y, Stone RM, Pandolfi PP, Kufe D, Avigan D.

Cancer Res. 2013 Sep 1;73(17):5569-79. doi: 10.1158/0008-5472.CAN-13-0677. Epub 2013 Jul 18.

39.

Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant.

Sengupta S, Tarsy D, Joyce R, Jeyapalan S.

Mov Disord. 2013 Nov;28(13):1905-6. doi: 10.1002/mds.25574. Epub 2013 Jul 9. No abstract available.

PMID:
23839936
40.

Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma.

Matasar MJ, Czuczman MS, Rodriguez MA, Fennessy M, Shea TC, Spitzer G, Lossos IS, Kharfan-Dabaja MA, Joyce R, Fayad L, Henkel K, Liao Q, Edvardsen K, Jewell RC, Fecteau D, Singh RP, Lisby S, Moskowitz CH.

Blood. 2013 Jul 25;122(4):499-506. doi: 10.1182/blood-2012-12-472027. Epub 2013 May 21.

41.

Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients.

Rosenblatt J, Avivi I, Vasir B, Uhl L, Munshi NC, Katz T, Dey BR, Somaiya P, Mills H, Campigotto F, Weller E, Joyce R, Levine JD, Tzachanis D, Richardson P, Laubach J, Raje N, Boussiotis V, Yuan YE, Bisharat L, Held V, Rowe J, Anderson K, Kufe D, Avigan D.

Clin Cancer Res. 2013 Jul 1;19(13):3640-8. doi: 10.1158/1078-0432.CCR-13-0282. Epub 2013 May 17.

42.

Disentangling neighborhood contextual associations with child body mass index, diet, and physical activity: the role of built, socioeconomic, and social environments.

Carroll-Scott A, Gilstad-Hayden K, Rosenthal L, Peters SM, McCaslin C, Joyce R, Ickovics JR.

Soc Sci Med. 2013 Oct;95:106-14. doi: 10.1016/j.socscimed.2013.04.003. Epub 2013 Apr 10.

43.

External phenome analysis enables a rational federated query strategy to detect changing rates of treatment-related complications associated with multiple myeloma.

Warner JL, Alterovitz G, Bodio K, Joyce RM.

J Am Med Inform Assoc. 2013 Jul-Aug;20(4):696-9. doi: 10.1136/amiajnl-2012-001355. Epub 2013 Mar 20.

44.

Unwarranted variability in antibiotic prophylaxis for cesarean section delivery: a national survey of anesthesiologists.

Raghunathan K, Connelly NR, Friderici J, Naglieri-Prescod D, Joyce R, Prasanna P, Ponnusamy N.

Anesth Analg. 2013 Mar;116(3):644-8. doi: 10.1213/ANE.0b013e318276cf72. Epub 2013 Feb 11.

PMID:
23400990
45.

Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program.

Shaughnessy P, Uberti J, Devine S, Maziarz RT, Vose J, Micallef I, Jacobsen E, McCarty J, Stiff P, Artz A, Ball ED, Berryman R, Dugan M, Joyce R, Hsu FJ, Johns D, McSweeney P.

Bone Marrow Transplant. 2013 Jun;48(6):777-81. doi: 10.1038/bmt.2012.219. Epub 2012 Nov 26.

PMID:
23178544
46.

Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma.

Barnes JA, Jacobsen E, Feng Y, Freedman A, Hochberg EP, LaCasce AS, Armand P, Joyce R, Sohani AR, Rodig SJ, Neuberg D, Fisher DC, Abramson JS.

Haematologica. 2013 Apr;98(4):615-9. doi: 10.3324/haematol.2012.075184. Epub 2012 Nov 9.

47.

Lenalidomide enhances anti-myeloma cellular immunity.

Luptakova K, Rosenblatt J, Glotzbecker B, Mills H, Stroopinsky D, Kufe T, Vasir B, Arnason J, Tzachanis D, Zwicker JI, Joyce RM, Levine JD, Anderson KC, Kufe D, Avigan D.

Cancer Immunol Immunother. 2013 Jan;62(1):39-49. doi: 10.1007/s00262-012-1308-3. Epub 2012 Jun 24.

48.

Chromatographic NMR with size exclusion chromatography stationary phases.

Joyce RE, Day IJ.

J Magn Reson. 2012 Jul;220:1-7. doi: 10.1016/j.jmr.2012.04.017. Epub 2012 May 8.

PMID:
22683575
49.

Meanings, motivations, and strategies for engaging in physical activity among women with multiple sclerosis.

Dlugonski D, Joyce RJ, Motl RW.

Disabil Rehabil. 2012;34(25):2148-57. doi: 10.3109/09638288.2012.677935. Epub 2012 Apr 25.

PMID:
22533641
50.

Interleukin-2 and regulatory T cells in graft-versus-host disease.

Koreth J, Matsuoka K, Kim HT, McDonough SM, Bindra B, Alyea EP 3rd, Armand P, Cutler C, Ho VT, Treister NS, Bienfang DC, Prasad S, Tzachanis D, Joyce RM, Avigan DE, Antin JH, Ritz J, Soiffer RJ.

N Engl J Med. 2011 Dec 1;365(22):2055-66. doi: 10.1056/NEJMoa1108188.

Supplemental Content

Support Center